Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00151762
Status:
COMPLETED
Last Update Posted:
2008-01-09
First Post:
2005-09-07
Brief Title:
Long-Term Study of Safety and Efficacy of WelChol as an Additional Therapy in Patients With Type 2 Diabetes
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Study Overview
Official Title:
A Multi-Center 52-Week Open-Label Extension Study From Studies WEL-301 WEL-302 and WEL-303 to Evaluate the Long-Term Safety and Tolerability of WelChol in Type 2 Diabetic Patients
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This extension study is designed to evaluate the long-term safety and tolerability of colesevelam hydrochloride WelChol in patients with type 2 diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None